Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marloes Dankers

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|August 28, 2023
Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisementsMarloes Dankers, Peeter Verlegh, Karla Weber, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 23, 2022
Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort studyMarloes Dankers, Karin Hek, Marjorie Nelissen-Vrancken, et al.
British Journal of Clinical Pharmacology|November 9, 2023
Adoption of new medicines in primary care: A comparison between the uptake of new oral anticoagulants and diabetes medicinesMarloes Dankers, Karin Hek, Aukje K Mantel-Teeuwisse, et al.
Pharmacology Research & Perspectives|May 2, 2021
Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals' preferencesMarloes Dankers, Marjorie H J M G Nelissen-Vrancken, Bertien H Hart, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[What can you do to … not be influenced?]Marloes Dankers, Peeter W J Verlegh, Karla Weber, et al.
Frontiers in Pharmacology|March 3, 2020
Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary DiseaseMarloes Dankers, Marjorie H J M G Nelissen-Vrancken, Sara M K Surminski, et al.
International Journal of Clinical Pharmacy|April 30, 2026
Barriers and facilitators for the implementation of medication safety recommendations: focus groups with stakeholdersMirthe A M Oude Lansink, Marcia Vervloet, Lise van Tholen, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 29, 2022
[Current and future therapeutic options for COVID-19]Marloes Dankers, H Marjorie J M G Nelissen-Vrancken, Marjolein Y Berger, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|August 28, 2023
Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisementsMarloes Dankers, Peeter Verlegh, Karla Weber, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 23, 2022
Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort studyMarloes Dankers, Karin Hek, Marjorie Nelissen-Vrancken, et al.
British Journal of Clinical Pharmacology|November 9, 2023
Adoption of new medicines in primary care: A comparison between the uptake of new oral anticoagulants and diabetes medicinesMarloes Dankers, Karin Hek, Aukje K Mantel-Teeuwisse, et al.
Pharmacology Research & Perspectives|May 2, 2021
Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals' preferencesMarloes Dankers, Marjorie H J M G Nelissen-Vrancken, Bertien H Hart, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[What can you do to … not be influenced?]Marloes Dankers, Peeter W J Verlegh, Karla Weber, et al.
Frontiers in Pharmacology|March 3, 2020
Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary DiseaseMarloes Dankers, Marjorie H J M G Nelissen-Vrancken, Sara M K Surminski, et al.
International Journal of Clinical Pharmacy|April 30, 2026
Barriers and facilitators for the implementation of medication safety recommendations: focus groups with stakeholdersMirthe A M Oude Lansink, Marcia Vervloet, Lise van Tholen, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 29, 2022
[Current and future therapeutic options for COVID-19]Marloes Dankers, H Marjorie J M G Nelissen-Vrancken, Marjolein Y Berger, et al.
Pageof 1